home / stock / jan / jan news


JAN News and Press, JanOne Inc. From 08/07/20

Stock Information

Company Name: JanOne Inc.
Stock Symbol: JAN
Market: NYSE
Website: janone.com

Menu

JAN JAN Quote JAN Short JAN News JAN Articles JAN Message Board
Get JAN Alerts

News, Short Squeeze, Breakout and More Instantly...

JAN - GRPN, CNDT, AYX and CAPR among midday movers

Gainers:  Conduent (NASDAQ: CNDT ) +75% . More news on: Conduent Incorporated, OpGen, Inc., Groupon, Inc., Stocks on the move, , Read more ...

JAN - JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications

LAS VEGAS , Aug. 6, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has entered into an agreement with CATO SMS, a world-leading, internat...

JAN - JanOne Changes Internal Drug Candidate Name from TV1001SR to JAN101

LAS VEGAS , Aug. 4, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, announces a internal name change for its current drug candidate f...

JAN - JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain

LAS VEGAS , July 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties has added two members to its impressive scientific...

JAN - FDA authorizes for transfer of JanOne' IND application for its Sodium Nitrite tablets

JanOne ( JAN +8.6% )  has received confirmation from the FDA for the IND sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience, to the company. More news on: JanOne Inc., Healthcare stocks news, Stocks on the move, Read more ...

JAN - JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets

LAS VEGAS , July 21, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain-relieving properties, has received confirmation from the Federal Food and Drug Administratio...

JAN - Dr. Rakesh Patel, internationally recognized scientist in nitric oxide and redox biology, and Dr. Timothy Ness, a pain mechanisms and medication expert, join JanOne's Scientific Advisory Board

LAS VEGAS , July 8, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, continues to broaden the medical and clinical competenc...

JAN - One of the nation's most renowned pain experts, Dr. Edgar Ross, joins JanOne's Scientific Advisory Board

LAS VEGAS , June 30, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties announced today that Edgar Ross , MD will join the com...

JAN - JanOne taps distinguished chemist Dr. Doug Flanagan as chief formulation advisor

LAS VEGAS , June 25, 2020 /PRNewswire/ -- JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, continues to build a world-class team of biopharma experts with the additio...

JAN - JanOne Launches Strategic Alternatives Process for Legacy Businesses

LAS VEGAS , June 18, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq:JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive pain relieving properties, today announced the commencement of a strategic alternative process for...

Previous 10 Next 10